Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abaxis management shuffle

This article was originally published in The Gray Sheet

Executive Summary

Firm names President and CEO Clint Severson as chairman of the board, replacing Abaxis co-founder Gary Stroy. Severson has been key to increasing revenue while reducing operational costs for the past seven quarters, the company says. Jim Canfield, former VP-marketing and sales at competitor Idexx Laboratories, joins Abaxis as VP-domestic marketing. Canfield replaces Vladimir Ostoich, who returns to his original position as VP-engineering. Chief Financial Officer and VP-finance Ting Lu is stepping down at the end of the month and will be replaced in the interim by Controller Reba Witwer. Other new appointments include Robert Milder as VP-operations; Larry Reynolds (VP-marketing and sales, Pacific Rim and Latin America) and Diane Oates (VP-regulatory affairs/quality systems)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel